Mar 2, 2021

Hahn-Schickard apppoints Professor Boris Mizaikoff as new Institute Director

Professor Boris Mizaikof joined the Hahn-Schickard Institute management team in January 2021
Source: Hahn-Schickard
Mar 2, 2021

The research and development service provider Hahn-Schickard added a fourth location in Ulm in 2020 to the already existing three institutes in Stuttgart, Villingen-Schwenningen and Freiburg. Together, the Freiburg and Ulm sites form the Hahn-Schickard Institute for Microanalysis Systems. 

Professor Boris Mizaikoff, who has headed the Institute of Analytical and Bioanalytical Chemistry at Ulm University since 2007, now joins the Hahn-Schickard Institute leadership with Professors Alfons Dehé, Yiannos Manoli, Felix von Stetten, Roland Zengerle and André Zimmermann. Mizaikoff will retain his professorship in Ulm and, together with Roland Zengerle, professor at the University of Freiburg, will serve as part-time director of the Hahn-Schickard Institute. Mizaikoff brings his long-standing research interests in the fields of photonics in liquids and gases and biomimetic receptors to the Hahn-Schickard portfolio.

Successful spin-offs and new collaborations: Hahn-Schickard network continues to grow

Hahn-Schickard recently exceeded 250 employees. One of several growth drivers is the Hahn-Schickard Institute for Microanalysis Systems, which was only founded in Freiburg in 2016 and currently has around 90 employees. In close strategic cooperation with the University of Freiburg and the joint spin-offs BioFluidix (2005), Cytena (2014), Spindiag (2016) and Actome (2018) and Dermagnostix (2020), this institute forms the core of Freiburg's high-tech network. It comprises more than 200 application-oriented research scientists in the fields of point-of-care diagnostics (rapid diagnostics in patients' homes), lab-on-a-chip, microfluidics and 3D bioprinting (tissue engineering).

Contact: Katrin Grötzinger, Hahn-Schickard
info@hahn-schickard.de

Member profile

Recommended articles

Dec 23, 2024

An innovative system to perform routine accuracy testing of automated liquid handling systems has been developed at CSEM in collaboration …

Apr 2, 2024

A new type of bioreactor that can grow human veins in the lab has been developed by CSEM and ClexBio, …

May 2, 2025

The Executive Board of the IVAM Microtechnology Network has appointed Tim Merforth as its new Managing Director. The digitalization expert …

Recommended events

Sep 10 - 12, 2025
Special Exhibiting Area ‘’Manufacturing Processes and Components for Medical Technology’’
Nov 17 - 20, 2025
Product Market “High-tech for Medical Devices”: A hub for high-tech solutions and medical innovations. Team up with IVAM to pave your way to trade fair success!
Sep 9 - 11, 2026
Manufacturing Processes for Medical Technology